Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...
Analysts have set 12-month price targets for Voyager Therapeutics, revealing an average target of $18.93, a high estimate of ...
In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a ...
1d
Zacks.com on MSNVoyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue EstimatesVoyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Voyager Therapeutics (VYGR) to $10 from $12 and keeps an Overweight rating on ...
Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter. On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents. The ...
VOYAGER THERAPEUTICS ($VYGR) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting revenue ...
S&P 500 E-Mini futures (ESH25) are up +0.41%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.53% this morning, pointing ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
Explore the detailed Voyager Therapeutics Inc balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total ...
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results